| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2003PNAS..100.4748N |
| P356 | DOI | 10.1073/PNAS.0637450100 |
| P932 | PMC publication ID | 153627 |
| P698 | PubMed publication ID | 12644709 |
| P5875 | ResearchGate publication ID | 7904193 |
| P50 | author | Tze Kin Lau | Q51980546 |
| Enders Kai-on Ng | Q57035518 | ||
| P2093 | author name string | Nancy B Y Tsui | |
| Rossa W K Chiu | |||
| Y M Dennis Lo | |||
| Lydia C W Lit | |||
| Nirmal S Panesar | |||
| Tse N Leung | |||
| Kam-Wing Chan | |||
| P2860 | cites work | Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays | Q28140044 |
| Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum | Q28207159 | ||
| Establishment of functional imprinting of the H19 gene in human developing placentae | Q28297145 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| High density synthetic oligonucleotide arrays | Q29616560 | ||
| Interference in immunoassay | Q33787432 | ||
| Fetal DNA in maternal plasma: emerging clinical applications | Q34351279 | ||
| Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins | Q34385179 | ||
| Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
| Microsatellite alterations in serum DNA of head and neck cancer patients | Q34394745 | ||
| Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. | Q38703501 | ||
| Telomerase RNA as a detection marker in the serum of breast cancer patients | Q40741742 | ||
| Absolute quantification of human chorionic gonadotropin-beta mRNA with TaqMan detection. 4. | Q40866201 | ||
| Growth hormone and placental lactogen: biology, medicine and biotechnology | Q41757877 | ||
| Progress in the knowledge of circulating nucleic acids: plasma RNA is particle-associated. Can it become a general detection marker for a cancer blood test? | Q44079687 | ||
| Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. | Q44079689 | ||
| Two-way cell traffic between mother and fetus: biologic and clinical implications. | Q44133343 | ||
| Stability of endogenous and added RNA in blood specimens, serum, and plasma | Q44153103 | ||
| Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. | Q45748068 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia | Q57671390 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21 | Q73045748 | ||
| Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses | Q73093957 | ||
| Presence of fetal RNA in maternal plasma | Q73162878 | ||
| Detection of apoptotic fetal cells in plasma of pregnant women | Q73742967 | ||
| New strategy for prenatal diagnosis of X-linked disorders | Q74053620 | ||
| Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum | Q74250288 | ||
| Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics | Q74509297 | ||
| Detection of fetal RHD-specific sequences in maternal plasma | Q77429872 | ||
| Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation | Q77678904 | ||
| Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum | Q77785524 | ||
| Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia | Q77945374 | ||
| Detection of tumor messenger RNA in the serum of patients with malignant melanoma | Q78206813 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4748-4753 | |
| P577 | publication date | 2003-03-18 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | mRNA of placental origin is readily detectable in maternal plasma | |
| P478 | volume | 100 |
| Q35098137 | A comparison of cell-free placental messenger ribonucleic acid and color Doppler ultrasound for the prediction of placental invasion in patients with placenta accreta |
| Q34997703 | A novel blood collection device stabilizes cell-free RNA in blood during sample shipping and storage |
| Q34260317 | Antioxidant supplementation in pregnant women with low antioxidant status. |
| Q24653435 | Applicability of non-invasively collected matrices for human biomonitoring |
| Q27025112 | Biomarkers for ectopic pregnancy and pregnancy of unknown location |
| Q34277918 | Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction |
| Q38371846 | Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation |
| Q37169269 | Cell-free fetal DNA and non-invasive prenatal diagnosis |
| Q35966472 | Cell-free fetal DNA in maternal blood: kinetics, source and structure |
| Q28241617 | Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound |
| Q36152745 | Cell-free fetal DNA in the maternal circulation and its future uses in obstetrics |
| Q39778751 | Cell-free fetal nucleic acids as prenatal biomarkers |
| Q34768792 | Cell-free fetal nucleic acids in amniotic fluid |
| Q36047180 | Chorioamnionitis Occurring in Women With Preterm Rupture of the Fetal Membranes Is Associated With a Dynamic Increase in mRNAs Coding Cytokines in the Maternal Circulation |
| Q38864230 | Circulating Levels of Pregnancy-Associated, Placenta-Specific microRNAs in Pregnant Women With Placental Abruption |
| Q53402026 | Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia. |
| Q56979217 | Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis |
| Q26825718 | Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q36790198 | Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis |
| Q35648376 | Circulating tumour cells in breast cancer |
| Q34640418 | Comparative transcriptome analysis reveals early pregnancy-specific genes expressed in peripheral blood of pregnant sows |
| Q58618243 | Comprehensive Analysis of Gene Expression Profiles and DNA Methylome reveals Oas1, Ppie, Polr2g as Pathogenic Target Genes of Gestational Diabetes Mellitus |
| Q58586693 | Current and future perspectives of liquid biopsies in genomics-driven oncology |
| Q88990659 | Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis |
| Q54639515 | Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. |
| Q34078379 | Detection of the placental epigenetic signature of the maspin gene in maternal plasma. |
| Q34239768 | Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies |
| Q34599011 | Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia |
| Q99631326 | Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women |
| Q53028411 | Does Formaldehyde Increase Cell Free DNA in Maternal Plasma Specimens? |
| Q34558118 | Epigenetic approaches for the detection of fetal DNA in maternal plasma |
| Q33797671 | Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker |
| Q36692481 | Evidence for a role for the adaptive immune response in human term parturition |
| Q27012889 | Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency |
| Q36654711 | Fetal DNA in maternal plasma: progress through epigenetics |
| Q59001540 | Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis |
| Q37948857 | Fetal nucleic acids in maternal blood: the promises |
| Q36275303 | First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR |
| Q45875805 | Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers |
| Q37483504 | Forensic pregnancy diagnostics with placental mRNA markers |
| Q43688745 | Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study |
| Q34286705 | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges |
| Q35995689 | Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. |
| Q54604267 | Genomewide oligonucleotide microarray analysis on placentae of pre-eclamptic pregnancies. |
| Q34023027 | Genomic targets in saliva |
| Q37031670 | Human placental trophoblasts confer viral resistance to recipient cells |
| Q33275493 | Hypermethylation of RASSF1A in human and rhesus placentas |
| Q37727372 | Identification of messenger RNA of fetoplacental source in maternal plasma of women with normal pregnancies and pregnancies with intrauterine growth restriction |
| Q26784480 | Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics |
| Q37229687 | Immunomodulatory role of microRNAs transferred by extracellular vesicles. |
| Q39785277 | Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia. |
| Q38613379 | Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics |
| Q40158974 | Investigation of biological factors influencing the placental mRNA profile in maternal plasma |
| Q33263722 | MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. |
| Q35888435 | Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction |
| Q39713024 | Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening |
| Q55424345 | MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT. |
| Q43169721 | Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood |
| Q38973677 | Measuring circulating placental RNAs to non-invasively assess the placental transcriptome and to predict pregnancy complications. |
| Q83351572 | Microparticles and placental hemostasis |
| Q46328658 | Microparticles and pregnancy complications |
| Q44933555 | Molecular diagnosis of severe acute respiratory syndrome |
| Q37181536 | Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment? |
| Q38088834 | Non-coding RNA and DNA as epigenetic biomarkers for pre-eclampsia |
| Q34149751 | Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities |
| Q36431820 | Non-invasive antenatal RHD typing |
| Q37809306 | Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age |
| Q36424760 | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications |
| Q57079533 | Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells |
| Q36117921 | Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis |
| Q38114375 | Non-invasive prenatal testing for aneuploidy: current status and future prospects |
| Q33665478 | Noninvasive in vivo monitoring of tissue-specific global gene expression in humans |
| Q37592253 | Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies |
| Q37010246 | Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma |
| Q58792515 | Novel Insights into Concepts and Directionality of Maternal⁻Fetal Cholesterol Transfer across the Human Placenta |
| Q43861652 | Nucleic acid-based non-invasive prenatal diagnosis of genetic skin diseases: are we ready? |
| Q90600016 | Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers |
| Q33466029 | Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood |
| Q36654715 | Placental RNA in maternal plasma: toward noninvasive fetal gene expression profiling |
| Q39359850 | Placental biomarkers for assessing fetal health |
| Q35892482 | Placental mRNA in maternal plasma as a predictor of ectopic pregnancy |
| Q34955670 | Placental mRNA in maternal plasma: prospects for fetal screening |
| Q37822751 | Placental microparticles, DNA, and RNA in preeclampsia |
| Q30667824 | Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments |
| Q37106761 | Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer |
| Q33268343 | Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection |
| Q37278804 | Potential markers of preeclampsia--a review |
| Q35853166 | Prediction of Fetal Growth Restriction by Analyzing the Messenger RNAs of Angiogenic Factor in the Plasma of Pregnant Women |
| Q56001884 | Pregnancy-Associated MicroRNAs in Maternal Plasma: A Channel for Fetal–Maternal Communication? |
| Q36673937 | Prenatal diagnosis: progress through plasma nucleic acids |
| Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
| Q73827217 | Probing the fetal genome: progress in non-invasive prenatal diagnosis |
| Q33643447 | Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status |
| Q34377985 | Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery |
| Q36063025 | Recent advances in fetal nucleic acids in maternal plasma |
| Q37000825 | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. |
| Q33237610 | Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping |
| Q54579005 | Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis. |
| Q39985314 | Saliva as a diagnostic tool for periodontal disease: current state and future directions |
| Q36691563 | Salivary mRNA targets for cancer diagnostics |
| Q34308038 | Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray |
| Q53610426 | Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. |
| Q46265145 | Stability of placental RNA using dried maternal blood spots |
| Q33770229 | Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome |
| Q34230033 | Systematic identification of spontaneous preterm birth-associated RNA transcripts in maternal plasma |
| Q90372343 | The 100 most-cited articles on prenatal diagnosis: A bibliometric analysis |
| Q35921812 | The Function of TrophomiRs and Other MicroRNAs in the Human Placenta |
| Q35667241 | The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis |
| Q35879299 | The biology and diagnostic applications of fetal DNA and RNA in maternal plasma |
| Q83193326 | The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis |
| Q35618934 | The four Rs of RNA-directed evolution |
| Q37636611 | The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. |
| Q61988365 | Toenails: an easily accessible and long-term stable source of DNA for genetic analyses in large-scale epidemiological studies. |
| Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
| Q35595108 | Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains |
Search more.